https://allsci.com/news/research/ai-designed-cancer-minibinders-university-of-bonn/ AllScien 2026-08-21T16:11:22.194264Z Protein charge emerges as key constraint for AI-designed cancer minibinders https://allsci.com/news/research/metabolic-vulnerability-cancer-danish-institute/ AllScien 2026-08-21T16:00:43.972614Z AKR1A1 loss exposes metabolic vulnerability in drug-resistant liver, kidney cancers https://allsci.com/news/licensing-and-partnerships/biosimilar-licensing-deal-alvotech-licenses-two/ AllScien 2026-08-21T15:55:04.953694Z Alvotech licenses two early-stage biosimilar candidates to Lotus for USD 150m https://allsci.com/news/licensing-and-partnerships/aav-capsid-engineering-vectorbuilder-and-lir-pair/ AllScien 2026-08-21T15:50:58.473456Z VectorBuilder, Lir apply AI to optimize AAV capsids for manufacturing https://allsci.com/news/licensing-and-partnerships/mrna-cancer-vaccines-metis-techbio-and-westvac/ AllScien 2026-08-21T15:46:19.575652Z METiS, WestVac team up on AI-designed personalized mRNA cancer vaccines https://allsci.com/news/funding/ambros-werewolf-merger-merges-with-raises-usd/ AllScien 2026-08-21T15:40:19.303397Z Ambros lands USD 150m financing in Werewolf reverse merger to fund neridronate Phase III